Oxbryta Tablet, For Suspension
Product Images NDC 72786-111
Product Visual Gallery
This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Oxbryta (NDC 72786-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Oxbryta 02)
Logo (Oxbryta 02a)
Logo (Oxbryta 02b)
Figure (Oxbryta 03)
Step 2 (Oxbryta 04)
Step 3 (Oxbryta 05)
Step 4 (Oxbryta 06)
Step 5 (Oxbryta 07)
Step 6 (Oxbryta 08)
Step 7 (Oxbryta 09)
Logo (Oxbryta 02c)
Principal Display Panel (500 mg Tablet Bottle Label)
Principal Display Panel (300 mg Tablet Bottle Label)
Principal Display Panel (300 mg Tablet Bottle Label)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.